Clinical Trials Logo

Filter by:
NCT ID: NCT02584738 Recruiting - Asthma Clinical Trials

Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation

Start date: September 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effectiveness of nebulized magnesium sulfate in patient with moderate to severe asthma exacerbation in pediatric emergency

NCT ID: NCT02563587 Recruiting - Pain Clinical Trials

Efficacy of Spontaneous Laughter in the Postoperative Treatment of Children

Start date: September 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the efficacy of laughter therapy in children to improve postoperative, evaluating the intensity of postoperative pain, anxiety and hospital stay.

NCT ID: NCT02555800 Recruiting - Clinical trials for Recurrent Respiratory Papillomatosis

Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis

Start date: December 2014
Phase: Phase 2
Study type: Interventional

The aim of this study is to compare the efficacy of intralesional bevacizumab, a monoclonal antibody against vascular endothelial growth factor, versus the antiviral drug cidofovir in patients with recurrent respiratory papillomatosis.

NCT ID: NCT02531412 Recruiting - Cancer Clinical Trials

Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients

SPIROCAN
Start date: October 2015
Phase: Phase 2/Phase 3
Study type: Interventional

Acute kidney injury frequently affects cancer patients. The main cause of acute kidney injury is ischemic damage caused by transient decrease in renal blood flow, followed by blood flow restoration and accompanying reperfusion injury (ischemia-reperfusion injury. Several studies, mainly in animal models have tried to establish spironolactone role on kidney injury induced by ischemia-reperfusion injury. It has been demonstrated in renal transplant recipients that the administration of spironolactone can prevent oxidative stress and is safe. The group of cancer patients with states capable of producing tissue hypoperfusion (hypovolemic shock, heart failure, major surgery, use of anesthetics) are at increased risk of developing acute renal ischemia-reperfusion injury. The investigators hypothesis is that spironolactone may be useful in preventing acute renal injury when administered during the first six hour of renal ischemia-reperfusion insult. The purpose of this study is to determine the utility of spironolactone administered after an ischemic renal insult (major surgery) to prevent acute kidney injury in critically cancer patients. Investigators propose a pilot study, randomized, double blind, placebo controlled trial, approved by the local ethical committee, to compare the efficacy of spironolactone to prevent acute kidney injury in patients after major surgery. Investigators will include 12 patients in spironolactone group (25mg daily for three days) and 12 patients in placebo group.

NCT ID: NCT02530346 Recruiting - Colostomy Clinical Trials

Is Colostomy Closure Without Mechanical Bowel Preparation Safe in Pediatric Patients? Randomized Clinical Trial.

Start date: October 2015
Phase: N/A
Study type: Interventional

This study will help determine wether mechanical bowel preparation before a colostomy closure is necessary in pediatric population, in order to avoid surgery related complications (surgical site infection and anastomosis leakage). Half of the population will go through the mechanical bowel prep before colostomy closure and the other half won´t. Complications rate will be compared among both groups.

NCT ID: NCT02523326 Recruiting - Clinical trials for Periodontal Disease Unrecognized Condition

Design of a Protocol for Obtaining Genomic DNA From Saliva

DPOGDNAS
Start date: February 2015
Phase: N/A
Study type: Observational

Objective The aim of this study was to test a protocol for the extraction of high quality genomic DNA from saliva samples obtained with mouthwash and taken from patients with periodontal disease. Materials and methods Saliva samples were taken from 60 patients, then stored at room temperature. DNA extraction was carried out at distinct post-sampling times (10, 20 and 30 days). Evaluation of genomic DNA was performed with spectrophotometry, electrophoresis, and PCR genotyping and sequencing.

NCT ID: NCT02510027 Recruiting - Cervical Cancer Clinical Trials

Triage Strategies in Cervical Cancer Prevention

FRIDA
Start date: August 2013
Phase: N/A
Study type: Observational

While there is broad consensus that HR-HPV detection is the best available primary screening test, there is no agreement about the most efficient and reliable triage procedure for HR-HPV positive women. Transient HR-HPV infections are very common, and the vast majority of these infections spontaneously regress after a year or two. Only a small fraction of cases will lead to persistent infection responsible for cervical neoplasia. The FRIDA Study is a large, population-based study that was designed to evaluate the performance and cost-effectiveness of different triage strategies for hrHPV-positive women in Mexico.

NCT ID: NCT02502240 Recruiting - Lung Cancer Clinical Trials

ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)

Start date: July 2015
Phase: N/A
Study type: Observational [Patient Registry]

Evaluation of the frequency and clinical characteristics of ALK rearrangements in Latin-American countries. Latin American countries are heterogeneous in terms of lung cancer incidence, ethnicity, and exposure to potential carcinogens. The discovery of the echinoderm microtubule-associated protein like 4-anaplastic lymphoma kinase (EML4-ALK) translocation as an oncogenic driver has led to the development of novel therapies with activity in vitro and in the clinic.

NCT ID: NCT02496182 Recruiting - Pulmonary Fibrosis Clinical Trials

Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment

Picheon
Start date: July 2015
Phase: Phase 2/Phase 3
Study type: Interventional

The Chronic Hypersensitivity Pneumonitis (HP), is an inflammatory disease who has an evolution to develop progressive interstitial fibrosis, who cause the death of the patient. Actually HP has been treated with Prednisone and occasionally with Azathioprine, but unfortunately the treatment with these drugs have not an effective result to treat the interstitial fibrosis. Pirfenidone has been studied over the world for the treatment of Fibrotic diseases, with positive results, and due to the Pirfenidone mechanism of action has anti-inflammatory and anti-fibrotic properties, the investigators propose to evaluate the addition of Pirfenidone to the actual treatment with Prednisone and Azathioprine in the treatment of patients with Pulmonary Fibrosis secondary to a Chronic Hypersensitivity Pneumonitis.

NCT ID: NCT02484573 Recruiting - Liver Cirrhoses Clinical Trials

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Start date: May 2015
Phase: N/A
Study type: Interventional

This study seeks to investigate whether non-selective beta blocker treatment decreases intestinal permeability in cirrhotic patients by altering the expression of genes encoding intercellular junction proteins.